Pursuit Wealth Management’s Pfizer PFE Stock Holding History

Pursuit Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$363K	Buy	+14,569	New	+$367K	0.31%	104

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pursuit Wealth Management's PFE Position: Q4 2025 in Review

Pursuit Wealth Management opened a new position in Pfizer (PFE) in Q4 2025: 14,569 shares worth $363K. The stake represents 0.31% of the portfolio and ranks #104 among its holdings.

2,907 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Pursuit Wealth Management held 14,569 shares of Pfizer worth $363K as of Q4 2025.
Pfizer was a new Pursuit Wealth Management position in Q4 2025.
Pfizer made up 0.31% of Pursuit Wealth Management's portfolio in Q4 2025, its #104 holding.
2,907 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Pursuit Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.